MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year operating income growth rate
Latest
8.70%
↑ 101% vs avg
Percentile
P85
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-1659.85%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 8.70% |
| Q3 2025 | -17.69% |
| Q2 2025 | -27.83% |
| Q1 2025 | 4.23% |
| Q4 2024 | -15.00% |
| Q3 2024 | -40.99% |
| Q2 2024 | -54.28% |
| Q1 2024 | -31.88% |
| Q4 2023 | -15.81% |
| Q3 2023 | 1.59% |
| Q2 2023 | -1.97% |
| Q1 2023 | 22.55% |
| Q4 2022 | -13.04% |
| Q3 2022 | 16.32% |
| Q2 2022 | -10.73% |
| Q1 2022 | -11.66% |
| Q4 2021 | -127.81% |
| Q3 2021 | 80.82% |
| Q2 2021 | -34628.92% |
| Q1 2021 | 6.60% |
| Q4 2020 | 0.00% |